Remarkably, similar sensitivity and specificity was disclosed by the “PanCancer” panel (APC, FOXA1 and RASSF1A) compared to other gene methylation panels proposed for individual BrC, CRC and LC detection [15,17,24,26]. The gene discussed is FOXA1; the disease is colorectal carcinoma.